Proportion of isolates with decreased susceptibility or resistance in Canada

Canada: Proportion of isolates with decreased susceptibility or resistance was 1.4 in 2020. ◆ Volatile

Latest (2020)
1.4
Change on year
up 191.5%
World rank
7th
of 52 countries
All-time high
7.34
in 2010
All-time low
0.4778
in 2017
Years of data
11
2009–2020

Proportion of isolates with decreased susceptibility or resistance in Canada, 2009–2020

024682009201420202009: 3.12010: 7.32011: 6.22012: 5.52013: 3.52014: 3.32015: 3.52016: 1.82017: 0.4782018: 0.482020: 1.4

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for proportion of isolates with decreased susceptibility or resistance in Canada is 1.4, measured in 2020.

Compared with earlier readings it is up 191.5% on the previous year and down 80.9% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Canada peaked at 7.34 in 2010 and was at its lowest, 0.4778, in 2017.

Canada ranks 7th of 52 countries on this measure, in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Canada, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP in Canada, 2009 to 2020.
Year Value Change
2009 3.09
2010 7.34 +137.5%
2011 6.19 -15.7%
2012 5.53 -10.6%
2013 3.51 -36.7%
2014 3.25 -7.2%
2015 3.48 +7.2%
2016 1.76 -49.4%
2017 0.4778 -72.9%
2018 0.4803 +0.5%
2020 1.4 +191.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 3.09 3.09 3.09 1
2010s 3.56 0.4778 7.34 9
2020s 1.4 1.4 1.4 1

Countries ranked near Canada

  1. 4 Viet Nam 6.09 compare
  2. 5 Japan 3.7 compare
  3. 6 Singapore 2.2 compare
  4. 8 Bhutan 1 compare
  5. 9 Mongolia 0.7752 compare
  6. 10 Belgium 0.6 compare

See the full ranking of 52 places →

More health data for Canada

All data for Canada →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Canada?
Proportion of isolates with decreased susceptibility or resistance in Canada was 1.4 in 2020, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Canada?
The highest recorded value was 7.34 in 2010.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Canada?
The lowest recorded value was 0.4778 in 2017.
How does Canada rank for proportion of isolates with decreased susceptibility or resistance?
Canada ranks 7th out of 52 countries with data for 2020.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in Canada?
Over the last ten years it is down 80.9%. The long-run trend across the full record is volatile.
Where does this Canada data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Canada. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 11 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/canada/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/canada/">Proportion of isolates with decreased susceptibility or resistance in Canada</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
52 places, 454 data points, 2009–2020
Last refreshed